Exact Sciences
NOTES: Exact Sciences: The $21B Blood Mirage: Exact Sciences' Oncology Fleecing
Exposing the Adjusted EBITDA double-speak behind Exact Sciences' precision oncology pipeline and the structural trap of the early cancer detection market.
Exact Sciences
Exposing the Adjusted EBITDA double-speak behind Exact Sciences' precision oncology pipeline and the structural trap of the early cancer detection market.
Cassandra Protocol
02 October 2026. The Q4 archives open on Natera and the brittle architecture of precision oncology. We dissect the miracle of early cancer detection against the crumbling infrastructure of healthcare reimbursement. Step into the cold and press play.
Medical Technology
On 30 September 2026, the Cassandra Archive pulls the ledger on Guardant Health. We explore the silent gap between the promised medical miracles of precision oncology and a corporate casino built on human plasma.
Cassandra Protocol
Accessing the Cassandra Archive for 22 September 2026. We pull the ledger on Viking Therapeutics and Hims & Hers, exposing the structural deficit and metabolic tollbooth of the modern telehealth industry.
Cassandra Protocol
On 14 September 2026, the Cassandra Archive opens the ledger on Boston Scientific's neuromodulation market. Discover the financialization of the human nervous system in this cyberpunk audio drama.
Cassandra Protocol
Unsealed on 12 September 2026, File S01E86 of the Cassandra Protocol audio drama explores the cyberpunk reality of Abbott's neuromodulation implants and the biological ledger of proprietary medical hardware.